๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Locally Advanced Non-Small Cell Lung Cancer
Clinical trial register · China

Locally Advanced Non-Small Cell Lung Cancer Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Shanghai 4 Guangzhou 3 Chongqing 1 Lanzhou 1 Jinan 1
Narrow the registerReset
Recruitment status
Phase
Site location
Shanghai4 Guangzhou3 Chongqing1 Lanzhou1 Jinan1
All 7 locations
Target enrolment
to

Locally Advanced Non-Small Cell Lung Cancer trials in China

10 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Neoadjuvant SBRT Followed by Sintilimab Plus Chemotherapy for N3-Positive NSCLC
NCT07309952Locally Advanced Non-Small Cell Lung Cancer, Stage IIIb Non-small Cell Lung Cancer, Stage IIIC Non-Small Cell Lung Cancer
Yang Hong
Phase 2
28
Guangzhou
2025-12-31
Recruiting
Targeted Induction Therapy for Stage III Unresectable EGFR Mutant Positive NSCLC
NCT07742332EGFR, NSCLC (Non-small Cell Lung Cancer), Locally Advanced Non-Small Cell Lung Cancer, Radiotherapy
Peng Zhang
Phase 2
160
Shanghai
2025-11-25
Recruiting
Hypofractionated Versus Conventional Chemoradiotherapy Followed by Consolidative Immunotherapy in Locally Advanced NSCLC
NCT07052669Locally Advanced Non-Small Cell Lung Cancer
Sun Yat-sen University
Phase 3
311
Chongqing, Lanzhou, Guangzhou
2025-07-01
Not yet open
Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Monoclonal Antibody in Locally Advanced NSCLC
NCT06837948Locally Advanced Non-Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
160
Shanghai
2025-02-18
Recruiting
RAPART in Locally Advanced Non-small Cell Lung Cancer Patients
NCT07164885Locally Advanced Non-small Cell Lung Cancer
Capital Medical University
Not applicable
911
Shenzhen
2025-02-17
Recruiting
Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer
NCT06734702Neoadjuvant Therapy, Concurrent Chemoradiotherapy, Immunotherapy, Locally Advanced Non-Small Cell Lung Cancer
Sun Yat-sen University
Phase 3
497
Guangzhou
2024-11-30
Recruiting
Neoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemotherapy for Resectable Locally-advanced EGFR Mutation-positive Non-Small Cell Lung Cancer
NCT06755684EGFR, Non-Small Cell Lung Cancer, Locally Advanced Non-Small Cell Lung Cancer, Pemetrexed
Peng Zhang
Phase 2
60
Shanghai
2024-11-07
Recruiting
Radiotherapy Plus Anlotinib in LA-NSCLC Intolerable to cCRT
NCT07037680Locally Advanced Non-Small Cell Lung Cancer, Thoracic Radiotherapy, Safety
JIANYANG WANG
Phase 2
44
Beijing
2024-01-01
Recruiting
Induction Chemoimmunotherapy in Combination With Chemoradiotherapy and Consolidation Immunotherapy in Unresectable Locally Advanced Non-Small Cell Lung Cancer
NCT07632365Non-Small Cell Lung Cancer, Locally Advanced Non-Small Cell Lung Cancer, Unresectable Stage III NSCLC
Shanghai Chest Hospital
Phase 1/2
108
Shanghai
2022-10-09
Recruiting
Patient's Whole Process Follow-up Management(HOPE-1)
NCT05339568Locally Advanced Non-Small Cell Lung Cancer, Metastatic NSCLC
Qianfoshan Hospital
Observational
1,268
Jinan
2022-05-22
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/condition/locally-advanced-non-small-cell-lung-cancer

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies listing the condition Locally Advanced Non-Small Cell Lung Cancer.

How many Locally Advanced Non-Small Cell Lung Cancer trials are recruiting in China?

9 of the 10 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 1 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Locally Advanced Non-Small Cell Lung Cancer), 10 studies
PhaseStudiesRecruitingShare
Phase 25450%
Phase 32220%
Not applicable1110%
Observational1110%
Phase 1/21110%

Most active sponsors

Lead sponsors with the most studies (Locally Advanced Non-Small Cell Lung Cancer)
Lead sponsorStudiesRecruiting
Peng Zhang22
Sun Yat-sen University22
Capital Medical University11
JIANYANG WANG11
Qianfoshan Hospital11
Shanghai Chest Hospital11
Shanghai Pulmonary Hospital, Shanghai, China10
Yang Hong11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.